Results 71 to 80 of about 20,877 (256)
Allergic Cutaneous Drug Eruptions with Quetiapine: A Case Study. [PDF]
Joshi M, Kar SK.
europepmc +1 more source
Hydroxychloroquine-induced repetitive atypical pustular drug eruptions in the same patient separated by 12 years. [PDF]
Chen J +4 more
europepmc +1 more source
Fixed Drug Eruption with Pigmentation Induced by Etoricoxib: A Case Report
Fixed drug eruption with pigmentation is characterized by the appearance of erythematous or bullous lesions following the ingestion of certain medications.
Dextre-Vilchez, Sergio Armando +1 more
doaj +1 more source
Pseudoephedrine-induced Fixed Drug Eruption in a Scuba Diver With Recurrent Palmoplantar Exfoliation [PDF]
This report presents a case of pseudoephedrine-induced non-pigmented bullous fixed drug eruption (NBFDE) manifesting as recurrent palmoplantar exfoliation in a scuba diver.
Pimpreeya Kajornchaikul +2 more
doaj +1 more source
Fixed Drug Eruptions With Flavoured Liquid Formulations of Over-the-Counter Analgesics: A Case Report. [PDF]
Alzahrani AH.
europepmc +1 more source
Iododerma after Lugol use for pre-operative preparation of thyroidectomy
A 35-year-old man with hyperthyroidism reported the sudden occurrence of ulcerated and painful oral lesions, painful ulcerative-necrotic lesions on the face, trunk, upper and lower limbs and purpuric circinate lesions on the scalp, 6 days after starting ...
David Almeida +6 more
doaj
Histological patterns of cutaneous adverse drug reactions
Cutaneous adverse drug reactions (ADR) are skin conditions due to a drug, regardless of the way of administration. Knowledge about their frequency, clinical manifestations and histopathological patterns is essential for prevention and early diagnosis ...
Sonia Maria Neumann Cupolilo +5 more
doaj
Bullous Fixed Drug Eruption Induced by Paracetamol: Report of a Pediatric Case
Drug eruptions are among the most common adverse drug reactions, affecting approximately 3% of hospitalized patients. A fixed drug eruption (FDE) is a distinct drug-induced reaction pattern that characteristically recurs at the same skin or mucosal site.
Massimiliano Nino +3 more
doaj +1 more source
ABSTRACT Objectives Paronychia is a common and often painful cutaneous adverse event of epidermal growth factor receptor inhibitor therapy that can impair function and quality of life. We report the first known case of amivantamab‐associated paronychia successfully treated with 532‐nm potassium‐titanyl‐phosphate laser.
Emilee M. Dreifus +2 more
wiley +1 more source

